Skip to main content
. 2024 Jan 4;63(1):2301233. doi: 10.1183/13993003.01233-2023

FIGURE 1.

FIGURE 1

Screening, randomisation, treatment and follow-up of the study participants with moderate-to-severe autoimmune pulmonary alveolar proteinosis. rGM-CSF: recombinant granulocyte–macrophage colony-stimulating factor; WLL: whole lung lavage.